

BLOOD ESTRERASE PROFILE IN MICE AT ACUTE INTOXICATION BY 2-(О-CRESYL)-4Н-1,3,2- BENZODIOXAPHOSPHORIN-2-OXIDE
https://doi.org/10.36946/0869-7922-2016-2-25-30
Abstract
About the Authors
D. S. ProkofievaRussian Federation
V. I. Shmurak
Russian Federation
A. E. Krivoshein
Russian Federation
E. A. Bodryakova
Russian Federation
N. G. Voitenko
Russian Federation
References
1. Bahar F.G., Imai T. Aspirin Hydrolysis in Human and Experimental Animal Plasma and the Effect of Metal Cations on Hydrolase Activities. Drug MetabDispos. 2013; 41:1450–1456.
2. Clement. J.G.Importance of aliesterase as a detoxification mechanism for soman (piinacolylmethylphosphonofluoridate) in mice. Biochemical Pharmacology. 1984; 33 (23): 3807-3811.
3. Maxwell D.M., Brecht K.M., O’Neill B.L. The effect of carboxylesterase inhibition on interspecies differences in soman toxicity. Toxico. Lett. 1987;39(1):35-42.
4. Garrett T.L., Rapp C.M., Grubbs R.D., Schlager J.J., Lucot J.B. A murine model for sarin exposure using the carboxylesterase inhibitor CBDP. NeuroToxicology. 2010; 31: 502–508.
5. Yang Z.P., Dettbarn W.D.Prevention of tolerance to the organophosphorus anticholinesterase paraoxon with carboxylesterase inhibitors. BiochemPharmacol. 1998; 55(9):1419- 1426.
6. Clement J.G., Erhardt N. Serum carboxylesterase activity in various strains of rats: sensitivity to inhibition by CBDP (2-/o-cresyl/4H:1:3:2- benzodioxaphosphorin-2-oxide). Arch. Toxicol. 1990; 64(5): 414– 416.
7. Nomeir A.A., Abou-Donia M.B. Studies on the metabolism of neurotoxic tri-ocresyl phosphate. Toxicology. 1986; 38: 1-13.
8. Ellman G.L., Courtney K.D., Andres V.Jr., Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 1961. V.7.: 88-95.
9. Курдюков И.Д., Дубровский Я.А., Бабаков В.Н., Гончаров Н.В. Исследование полиморфизмов параоксоназы-1 у населения Кировской области. Токсикологический Вестник. 2012. №4, С. 13-18.
10. CarlettiE., SchopferL.M., ColletierJ.P., FromentM.T., NachonF., WeikM., LockridgeO., MassonP. ReactionofCresylSaligenin Phosphate, the Organophosphorus Agent Implicated in Aerotoxic Syndrome, with Human Cholinesterases: Mechanistic Studies Employing Kinetics, Mass Spectrometry, and X-ray Structure Analysis. Chem. Res. Toxicol. 2011; 24: 797 – 808.
11. Прокофьева Д.С., Кривошеин А.Е., Шмурак В.И., Бодрякова Е.А., Войтенко Н.Г. Определение оптимальной дозы 2-(о-крезил)-4Н-1,3,2-бензодиоксофосфорин-2-оксида для селективного ингибирования карбоксилэстераз сыворотки крови крыс invivo. Ученые записки Орловского государственного университета. 2014;7(63): 255-256.
12. Chambers J.P., Hartgraves S.L., Murphy M.R., Wayner M.J., Kumar N., Valdes J.J.Effects of three reputed carboxylesterase inhibitors upon rat serum esterase activity. Neurosci.Biobehav.Rev. 1991; 15(1):85-88.
13. Shapira S., Kadar T., Cohen G., Chapman S., Raveh L. Effects of CBDP and MEPQ on the toxicity and distribution of [3H]-soman in mice. Arch Toxicol. 1990;64(8):663-668.
Review
For citations:
Prokofieva D.S., Shmurak V.I., Krivoshein A.E., Bodryakova E.A., Voitenko N.G. BLOOD ESTRERASE PROFILE IN MICE AT ACUTE INTOXICATION BY 2-(О-CRESYL)-4Н-1,3,2- BENZODIOXAPHOSPHORIN-2-OXIDE. Toxicological Review. 2016;(2):25-30. (In Russ.) https://doi.org/10.36946/0869-7922-2016-2-25-30